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ful and prior studies in humans have demonstrated that an impedance fall
of 20 ohms is predictive of coagulum formation or a loss of AP conduction.
The purpose of this study was to prospectively quantitate the correlation be-
tween impedance and temperature during RF ablation of APs. Thirty-three
consecutive patients, each with a single AP. underwent RF ablation using
a thermistor ablation catheter. Temperature and impedance were continu-
ally recorded during each RF application. The initial and final temperatures
and impedance measurements for 319 applications of RF energy were ana-
lyzed. The initial and final impedance and temperature measurements were
109 ± 17 ohms and 102 ± 17 ohms (p < 0.000t). and 37 ± 1°C and 57 ±
11°C (p < 0.0001). Among the 319 applications of RF energy, 158 were as-
sociated with 2:20°C increase in tissue temperature. There were 10 applica-
tions of RF energy associated with coagulum formation. A 2:20°C increase
in tissue temperature was observed in 84 of 104 applications associated
with a 5-10 ohm decrease in impedance (81 % positive predictive value and
93% negative predictive value). The mean change in impedance for applica-
tions associated with and without coagulum formation was -19 ± 7 ohms
and -6 ± 6 ohms (p < 0.0001), respectively, and was never less than 12
ohms. In conclusion, successful tissue heating without coagulum formation
can be achieved by titrating the power to achieve a 5-10 ohm decrement in
impedance. Impedance decrements beyond 10 ohms increase the likelihood
of excessive tissue heating and coagulum formation.
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was 60 seconds or until impedance rise occurred. Lesion dimensions were
determined by stereomorphometric analysis.
Results: A total of 77 lesions were analyzed. Lesion volume increased with
higher power from 40 to 60W (0.61 ± 0.08 cm3 vs. 1.01 ± 0.10 cm3 , P =
0.006) (Figure). Beyond 50W, power duration was progressively limited by
earlier impedance rise (Figure) and was associated with diminished lesion
volume at 70W (0.71 ± 0.44 cm3 ; P = 0.04, 60 vs 70WI.
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Conclusion: A dose-response relationship for chilled-tip RF ablation can
be demonstrated in vivo, and lesion volume is maximized with RF power of
60W, a value substantially higher than that found with standard RF ablation.
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PTCA And Thrombolytic Therapy in AMI
Eighty-four patients (age 43 ± 28 years) suffering from refractory tachycar-
dia underwent RF ablation: 48 patients with an accessory pathway (left side
29, right side 19), 24 patients with ventricular tachycardia (ischemic 13, idio-
pathic 11) and 12 with junctional tachycardia. Continuous transesophageal
echocardiography (TEE) was performed during the procedure - mean dura-
tion 124 rain (48-212) - and RF was delivered with an average of 15 applica-
tions (1-351, energy of 31.2 Watts (20-40) and temperature of 68°C (47-84)
during 48.6 min (20-66) with a heparine anticoagulation (ACT x 2 to 3).
TEE demonstrated a progressive micro-cavitations advent during 29% of
the sessions (WPW: 68%; VT: 42%; junctional T: 25%). preceding with an
average of 32 sec (10-66), a major rise of impedance (>200 Q). No relation-
ship was found between the micro-cavitations appearance and RF success,
tip temperature, initial power and anticoagulation level. There is a correla-
tion (r = 0.68 p < 0.05) between micro-cavitations and both impedance level
(2: 120 Q) and catheter endocardial-contact estimated by the injury current of
the unipolar catheter recording (2:8 mY). A charred thrombus was seen at the
catheter tip in all cases when the catheter was withdrawal, micro-thrombus
«2 mm) at the echogenic bubbles appearance and macro-thrombus (>2
mm) when impedance increases. In the mean time, if micro-cavitations occur
during a first application without or with a slight impedance rise, successive
applications with the same catheter lead to an enhancement of echogenic
bubbles and finally to the impedance increase.
These results suggest that the micro-cavitations observed with TEE during
RF ablations are linked to the beginning of a thrombus formation related to
endocardial lesions resulting from an overrated catheter contact pressure
and tip-delivered energy.
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1777-61 Assessment of Radiofrequency Boiling and
Thrombus Formation During Catheter Ablation by
Transesophageal Echocardiography
Yves Gallais, Gilles Lascault, Joelci Tonet, Philip Aouate, Fernando Rosas,
Jorge Elias, Osamu Kinoshita, Robert Frank, Guy Fontaine. Hopital Jean Rostand.
Ivrx France
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1778-1 I Immediate Recognition of Patients Unlikely to Derive
Absolute Benefit from Thrombolytic Therapy for
Myocardial Infarction
S.M. Nidorf, R. Parsons, P.L. Thompson, K. Jamrozick, M.S.T. Hobbs. Dept of CV
Medicine and Public Health, DElI, Perth. Australia
Since thrombolyic therapy (TI) is associated with a definite (0.4%) risk of
intra-cranial hemmorrhage, it would be desirable to detect patients (pt) pre-
senting with myocardial infarction (MI) who are at such low risk of death that
they would be unlikely to derive an absolute nett benefit from treatment.
In an attempt to identify these ptsatthe time ofdecision making, we devel-
oped a simple clinical model using Age <60, History of MI Diabetes or Out


















1777-41 Relationship Between Fluoroscopy Duration,
Ablation Target, and Success During Catheter
Ablation Procedures
Hugh Calkins, Ronald Berger, Gordon Tomaselli, John Lawrence, Jay Dinerman,
Robert Mittleman, Lawrence Klein, Eric Prystowsky, Paul Gillette, Patrick Yang,
Atakr Investigators. Johns Hopkins, Bait, MD
Radiation exposure is an important risk during ablation (abl) procedures. To
determine the relationship between the target arrhythmia, fluoroscopy time
(fluoro), and the success of abl procedures we analyzed data from 450 pa-
tients in the Atakr multicenter clinical study(217 F, 233 M, 38 ± 21 yrs). Target
arrhythmias included AVNRT (154 pts), the AV junction (54 pts, AVJ), and 241
accessory pathway (APs). Results: Similar success was achieved during abl
of APs, AVNRT. and the AVJ (93%, 98%, and 94% respectively, p > 0.1). In
contrast, fluoro time was greater during abl of APs than during abl of AVNRT
or the AVJ (62 ± 48, versus 31 ± 29 & 36 ± 24 min, p < 0.05). Cumulative
success of catheter abl of APs rose rapidly during the first 90 min of fluoro
exposure and then plateaued. In contrast. cumulative success during abl of
the AVJ and AVNRT plateaued after 40 and 70 min. Concl: Similar success
can be achieved during abl of APs, AVNRT. and the AVJ, but greater fluoro
is needed during abl of APs. Resultant radiation risk should be considered
when determining an appropriate termination point.
1777-51 The Relationship Between Impedance and
Temperature During Radiofrequency Ablation of
Accessory Pathways
S. Adam Strickberger, Srihari Ravi, Emile G. Daoud, Mark J. Niebauer, K.
Ching Man, Fred Morady University ofMichigan, Ann Arbor, MI
Temperature monitoring is a useful tool for radiofrequency (RF) ablation of
accessory pathways (AP). but this technology is not universally available and
is not suitable for some catheter designs. Impedance monitoring is also help-
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Results: Primary PTCA Thrombolysis
(l-year follow-up) (N ~ 152) IN = 166) P
Recurrent ischemia 12(8%) 54(33%) <0.0001
Recurrent MI 4(3%) 16(10%) <0.025
Mortality 7(5%) 4(2%) ns
Reocclusion rate 7(5%) 58 (35%) <0.0001
Mean diam, stenosis angio 1 27 ± 15% 56 ± 12% <0.0001
Mean diam. stenosis angio 2 35 ± 22% 68 ± 28% <0.0001
without reocclusion 31 ± 22% 48 ± 15% <0.0001
PTCA t-PA
Group A Group B Group A Group B
Time (mins) (n ~ 36) (n ~ 159) In ~ 38) (n ~ 162)
chest pain onset to randomization 211 ± 129 173± 116* 258 ± 179 183± 139t
randomization to t-PA bolus N/A N/A 34 ± 25 31 ± 22
randomization to cath lab arrival 43 ± 20 39 ± 18 N/A N/A
cath lab arrival to first angiogram 21 ± 9 20 ± 11 N/A N/A
first angiogram to reperfusion 19 ± 14 20 ± 24 N/A N/A
Hospital events
PTCA success 91.7% 94.3% N/A N/A
Death 5.6% 1,9% 7,9% 6.2%
Death or reinfarction 13.4% 3.1%§ 18.4% 105%£
Recurrent ischemia 16.7% 88%£ 34.2% 26.5%
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Is Primary Angioplasty Less Effective in Patients with
Acute Myocardial Infarction Presenting in the Early
Morning Hours?
Gregg W. Stone, Cindy L. Grines, Kevin F. Browne, Jean Marco, Donald Rothbaum,
James O'Keefe, Paul Overlie, Brian Donohue, Sylvia Puchrowicz, William W. O'Neill
£1 Camino Hospital, Mountain View- CA; William Beaumont Hospital, Royal Oak, MI
Concern has been expressed that delays in physician and cath lab mobiliza-
tion may adversely affect the feasibility and outcome of a primary angioplasty
strategy in pts with acute MI presenting in the early morning hours. In the
PAMI Trial, 395 pts within 12 hours onset of MI were prospectively random-
ized to t-PA (n = 200) vs. primary PTCA (n = 195). Demographic characteris-
tics were similar between pts presenting between 12 MN and 6 AM (Group
A) and 6 AM to 12 MN (Group B). Outcomes appear below:
Conclusion: Not only lesion diameter stenosis at first and second angiog-
raphy, but also reocclusion rate is much better with primary PTCA than with
thrombolysis. Apart from the very high reperfusion rate by PTCA for acute MI,
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Prehospital thrombolysis preserves LV function, but its impact on long-term
outcome has not yet been reported. We followed for 2-7 years, 362 patients
(pts) who received IV thrombolysis since prehospital strategy was started in
Jerusalem. CHF as judged by clinical symptoms and exercise performance
were compared between 68 pts who received prehospital streptokinase, at
1.2 ± 0.6 hours of chest pain onset (group II and 294 pts with in-hospital lysis
after 2.2 ± 1.0 hours (group II).
The difference in LV function measured at 1 week contrast ventriculogra-
phy was small - Group 1- EF 58 ± 15% vs Group II - 55 ± 14%, but a
striking and significant change was observed in CHF disability (NYHA Grade
II-IV) prevalence at follow-up.
Prehospital Thrombolysis in Acute MI Prevents
Symptoms of Congestive Heart Failure - A
Long-term Follow-up Study
A. Teddy Weiss, Dan Gilon, Iris Shviro, Dan Sapoznikov, Shimon Rosenheck,
Morris Mosseri, Chaim Lotan, Yoseph Rozenman, Mervyn S. Gotsman Cardiology
Department, Hadassah Hospitals, Jerusalem, Israel
arrival. and either 0 waves or LBBB on the initial ECG, to predict mortality at
28 days and 1 year after MI.
The model was developed in 5781 pts in the MONICA data base (1984--93)
who were <65 yo, seen 1-24 hrs after symptom onset, had an ECG and were
admitted to CCU. The model was then tested in another 1000 pts. Morbidity
and mortality at 28 days and 1 year was then examined in relation to risk
Score.
Results: Overall mortality at 28 days and 1 year was 4.2% and 7.0%. The
modelidentified 60% ofpts <60 yo at very low risk (Score = 0; Mortality 1%
at 28 days and <2% at 1 year), and proved equally sensitive, specific (90%)
and predictive of survival (99%) in the test group. Of the 2562 pts with either
ST elevation or LBBB on the initial ECG, 46% had a Score = O. In these pts
n was not associated with a reduction in mortality (0.9% vs 1.0%) or heart
failure (2.5%) at 28 days. In contrast, in pts with ST elevation or LBBB and a
Score> 0, n was associated with an absolute reduction in mortality at 28
days (4.6% vs 10.6%*) and 1 year (6.1 % vs 16.1 %*); *p < 0.01.
Conclusion: In pts presenting with MI, it is possible to readily identify those
at very low (1 %) risk of death in whom the absolute benefit of n may be out
weighed by the absolute risk of treatment.
Similar significant changes between the two groups were observed for
other complaints: pulmonary edema, orthopnea, paroxysmal nocturnal dys-
pnea, nocturia, peripheral edema, fatigue and angina pectoris.
Thus, time gain through prehospital lysis prevents CHF symptoms and
long-term disability and justifies more extensive use of early thrombolysis.
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Better Vessel Status with Less Reocclusion at 3
Months as Additional Mechanism for Improved
Outcome of Primary Angioplasty for Acute
Myocardial Infarction
Gerrit Veen, Menko Jan de Boer, Felix Zijlstra, Freek WA. Verheugt. Free University
Hospital, Amsterdam, Hospital De Weezenlanden, Zwolle, The Netherlands
Primary angioplasty IPTCA) for acute myocardial infarction (MI) is associated
with improved clinical outcome (less recurrent ischemia and myocardial in-
farction), when compared to thrombolytic therapy. We sought to determine,
whether these differences were related to differences in angiographic out-
come during follow-up.
In the Zwolle-trial primary PTCAwas compared to streptokinase treatment.
However, in the thrombolysis group only a follow-up angiography was per-
formed. Therefore, in these patients (pts) successful reperfusion and reoc-
c1usion rate could not be determined.
In this report we compared quantitative angiographic and clinical follow-
up data of the pts randomized to primary angioplasty in the Zwolle-trial with
data of the APRICOT-trial, in which all pts received thrombolysis. Both study
groups had angiographically documented reperfusion of the infarct-related
artery and underwent a second angiography at 3 months. There were no
important differences in baseline characteristics.
*p < 0.09: t P~ 0.005: §p = 0.008: £p < 0.18. All other p ~ NS
Conclusions. Time to presentation is prolonged in pts with MI in the early
morning hours. No delays occur, however, in cath lab mobilization, PTCA per-
formance or success. Further studies are required to explain the apparently
worse prognosis of pts presenting between 12 MN and 6AM in this trial.
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1778-51 Timing and Mechanism of Death After Direct
Angioplasty for Acute Myocardial Infarction
Bruce Brodie, Thomas Stuckey, Richard Weintraub, Denise Muncy,
Charles Hansen, E. Joseph LeBauer, Thomas Kelly, Jonathan Berry. The Moses H.
Cone Memorial Hospital, Greensboro, N. C.
Of 907 pts with acute myocardial infarction treated with direct angioplasty
(PTCA) from 1984--93, 78 pts (86%1 died within 30 days. Of the 78 pts, 35
(45%) had cardiogenic shock prior to intervention, and an additional 4 (5%)
presented with acute pulmonary edema without shock. Twenty-eight pts
(36%1 died on day 0, 9 (12%) on day 1, and 10 (13%) on day 2. The mecha-
nisms of death were pump failure in 49 (63%), reinfarction in 7 (9%), rupture
in 5 (6.4%), arrhythmia in 3 138), other cardiac causes in 2 (2.6%), and non-
cardiac causes in 12 (15%). Almost all the early deaths (27/28) were due to
pump failure. Of 78 pts who died, 28 (36%) developed hemodynamic deteri-
oration or cardiac arrest immediately after reperfusion and 13 of these died
in the cath lab. Hemodynamic deterioration and cardiac arrest occurred less
often when intra-aortic balloon pumping (IABP) was initiated before PTCA vs
after PTCA or not at all (2/18 (11 %) vs 26/60 143%), P < 0.03).
Conclusion: Mortality after PTCA, like thrombolytic therapy, is the highest
in the first 24 hours, and this is almost always due to pump failure. Unlike
thrombolytic therapy, the incidence of death from rupture and arrhythmias
is relatively low. Early mortality is high partially due to the high incidence of
cardiogenic shock in our population, but some of the early mortality may be
related to hemodynamic deterioration occurring immediately after reperfu-
